Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 8351-8400 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04949750
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
NA
Active, not recruiting
200 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2025
1 condition
4 sponsors
1 location
NCT05248516
ComPAS Low-WAZ RCT Mali
PHASE2/PHASE3
Active, not recruiting
1,500 participants
Started: Sep 1, 2022 · Completed: Apr 30, 2024
3 conditions
3 sponsors
11 locations
NCT05479318
A Global Approach to Tackle Cognitive Decline
N/A
Active, not recruiting
1,502 participants
Started: Sep 1, 2022 · Completed: Oct 1, 2025
1 condition
7 sponsors
1 location
NCT05769673
Soft and Hard Tissue Changes Around Implants
NA
Active, not recruiting
30 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT06176599
Clinical Study on the Treatment of Diabetic Kidney Disease With Shenxiao Yuning Decoction With Syndrome of Qi and Yin Deficiency and Blood Stasis
NA
Active, not recruiting
60 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05352802
Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer
NA
Active, not recruiting
368 participants
Started: Sep 1, 2022 · Completed: May 1, 2027
2 conditions
13 sponsors
1 location
NCT05301400
Marginal Bone Loss in Single Implant Restaurations With Different Methods
NA
Active, not recruiting
59 participants
Started: Sep 1, 2022 · Completed: Mar 30, 2025
1 condition
1 sponsor
1 location
NCT05520294
Evaluating the Effects of Cannabis Use and Circulating Cannabinoids on Tumor Infiltrating Lymphocytes in Malignant Melanoma
N/A
Active, not recruiting
90 participants
Started: Sep 1, 2022 · Completed: Aug 31, 2024
1 condition
2 sponsors
1 location
NCT06298305
Artificial Intelligence & Prostate Cancer
N/A
Active, not recruiting
200 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05722041
Soft Tissue Volume Changes in Posterior Socket Sealing Abutment.
N/A
Active, not recruiting
20 participants
Started: Sep 1, 2022 · Completed: Feb 1, 2026
1 condition
1 sponsor
1 location
NCT05531487
A 14-item Questionnaire Regarding Career Preferences Among Chinese Medical Undergraduate Students.
N/A
Active, not recruiting
500 participants
Started: Sep 1, 2022 · Completed: Nov 30, 2023
2 conditions
1 sponsor
1 location
NCT07150104
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM
PHASE1/PHASE2
Active, not recruiting
14 participants
Started: Aug 31, 2022 · Completed: Mar 11, 2027
1 condition
1 sponsor
10 locations
NCT05252988
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
PHASE2
Active, not recruiting
177 participants
Started: Aug 31, 2022 · Completed: Jan 31, 2030
3 conditions
3 sponsors
55 locations
NCT05656118
Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR)
N/A
Active, not recruiting
260 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
10 locations
NCT05547672
Clinical Investigation to Assess a New Artificial Urinary Sphincter to Treat Urinary Incontinence in Men
NA
Active, not recruiting
6 participants
Started: Aug 31, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
2 locations
NCT05851144
South Texas Early Prevention Studies SNAP-Ed (STEPS SNAP-Ed)
NA
Active, not recruiting
1,104 participants
Started: Aug 31, 2022 · Completed: Sep 30, 2026
1 condition
4 sponsors
1 location
NCT05524584
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
PHASE2
Active, not recruiting
20 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2028
4 conditions
1 sponsor
1 location
NCT05273554
A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma
PHASE1
Active, not recruiting
14 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT05426434
Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy
PHASE3
Active, not recruiting
1,172 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2025
3 conditions
5 sponsors
1 location
NCT05357443
SH Dr. Chen Gastric Bypass Study
NA
Active, not recruiting
50 participants
Started: Aug 31, 2022 · Completed: Sep 30, 2027
1 condition
2 sponsors
1 location
NCT05387837
Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME
PHASE2
Active, not recruiting
50 participants
Started: Aug 31, 2022 · Completed: Sep 30, 2025
2 conditions
1 sponsor
16 locations
NCT05459844
A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs
PHASE3
Active, not recruiting
196 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
23 locations
NCT05475184
A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor
PHASE2
Active, not recruiting
58 participants
Started: Aug 31, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06173765
Understanding Dose Related Effects of Strawberry
NA
Active, not recruiting
66 participants
Started: Aug 31, 2022 · Completed: Jan 28, 2026
4 conditions
1 sponsor
1 location
NCT04711135
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
PHASE2
Active, not recruiting
11 participants
Started: Aug 31, 2022 · Completed: May 7, 2034
3 conditions
1 sponsor
7 locations
NCT05405296
Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2)
N/A
Active, not recruiting
1,480 participants
Started: Aug 30, 2022 · Completed: Sep 30, 2024
2 conditions
1 sponsor
1 location
NCT05348356
Nirogacestat in Ovarian Granulosa Cell Tumors
PHASE2
Active, not recruiting
53 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2027
3 conditions
1 sponsor
21 locations
NCT02793492
Misago® RX Self-expanding Peripheral Stent for Common And/or External Iliac Artery
NA
Active, not recruiting
75 participants
Started: Aug 30, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
9 locations
NCT05364697
IonMAN Trial- First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System
NA
Active, not recruiting
60 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2029
4 conditions
1 sponsor
4 locations
NCT06597045
BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS
N/A
Active, not recruiting
60 participants
Started: Aug 30, 2022 · Completed: Nov 20, 2024
3 conditions
3 sponsors
1 location
NCT05503251
Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases
PHASE2
Active, not recruiting
110 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05541380
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID)
N/A
Active, not recruiting
300 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2030
1 condition
1 sponsor
9 locations
NCT05433701
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
NA
Active, not recruiting
178 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05377450
Prospective Randomized Study of Cementless vs Cemented UKA
NA
Active, not recruiting
108 participants
Started: Aug 29, 2022 · Completed: May 31, 2025
1 condition
2 sponsors
1 location
NCT05470699
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer
NA
Active, not recruiting
30 participants
Started: Aug 29, 2022 · Completed: Apr 13, 2026
1 condition
2 sponsors
1 location
NCT05222815
Glucose Monitoring Comparison in Primary Care
NA
Active, not recruiting
360 participants
Started: Aug 29, 2022 · Completed: Oct 1, 2026
1 condition
2 sponsors
1 location
NCT05523375
Promoting Successful Weight Loss in Primary Care in Louisiana Using Information Technology
NA
Active, not recruiting
352 participants
Started: Aug 29, 2022 · Completed: Mar 31, 2026
3 conditions
4 sponsors
1 location
NCT05339386
Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension
N/A
Active, not recruiting
10 participants
Started: Aug 29, 2022 · Completed: Mar 31, 2025
1 condition
2 sponsors
1 location
NCT06674369
Ongoing Effect of Expansion Prisms Following the Discontinuation of Use on Visual Field Enlargement and Retrograde Ganglion Cell Degeneration in Homonymous Hemianopia Patients
N/A
Active, not recruiting
15 participants
Started: Aug 28, 2022 · Completed: Oct 30, 2024
1 condition
2 sponsors
1 location
NCT05669911
Development of a Self-collection Device for Cervical Cancer Screening
NA
Active, not recruiting
235 participants
Started: Aug 28, 2022 · Completed: Dec 31, 2023
3 conditions
1 sponsor
6 locations
NCT05500222
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
PHASE3
Active, not recruiting
700 participants
Started: Aug 26, 2022 · Completed: Jan 31, 2027
2 conditions
1 sponsor
55 locations
NCT05403385
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
36 participants
Started: Aug 26, 2022 · Completed: Oct 31, 2025
2 conditions
2 sponsors
21 locations
NCT06312826
Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk
NA
Active, not recruiting
806 participants
Started: Aug 26, 2022 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT05224661
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
N/A
Active, not recruiting
303 participants
Started: Aug 26, 2022 · Completed: Jul 1, 2029
1 condition
2 sponsors
18 locations
NCT05382637
Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
PHASE2
Active, not recruiting
1 participants
Started: Aug 26, 2022 · Completed: Sep 1, 2028
1 condition
1 sponsor
1 location
NCT05518045
Study of LM-108 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours
PHASE1/PHASE2
Active, not recruiting
392 participants
Started: Aug 26, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05370469
Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies
NA
Active, not recruiting
30 participants
Started: Aug 25, 2022 · Completed: Aug 31, 2025
9 conditions
1 sponsor
1 location
NCT05192889
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
PHASE1/PHASE2
Active, not recruiting
35 participants
Started: Aug 25, 2022 · Completed: Feb 28, 2027
2 conditions
2 sponsors
2 locations
NCT06047821
Enterics for Global Health (EFGH)
N/A
Active, not recruiting
9,800 participants
Started: Aug 25, 2022 · Completed: Apr 30, 2025
3 conditions
11 sponsors
33 locations
NCT05698290
HELP Pain Training Program
N/A
Active, not recruiting
68 participants
Started: Aug 25, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
165
166
167
168
169
170
171
More pages
431
Next